1. Home
  2. ORN vs STRO Comparison

ORN vs STRO Comparison

Compare ORN & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion Group Holdings Inc.

ORN

Orion Group Holdings Inc.

HOLD

Current Price

$16.18

Market Cap

555.4M

Sector

Industrials

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$29.07

Market Cap

491.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORN
STRO
Founded
1994
2003
Country
United States
United States
Employees
N/A
133
Industry
Military/Government/Technical
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
555.4M
491.0M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
ORN
STRO
Price
$16.18
$29.07
Analyst Decision
Strong Buy
Buy
Analyst Count
4
9
Target Price
$16.25
$31.33
AVG Volume (30 Days)
351.5K
251.2K
Earning Date
04-28-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
220.00
N/A
EPS
0.12
N/A
Revenue
$852,260,000.00
N/A
Revenue This Year
$8.50
N/A
Revenue Next Year
$7.83
N/A
P/E Ratio
$133.50
N/A
Revenue Growth
7.01
N/A
52 Week Low
$6.44
$0.67
52 Week High
$16.57
$43.85

Technical Indicators

Market Signals
Indicator
ORN
STRO
Relative Strength Index (RSI) 67.03 48.89
Support Level $13.20 $23.53
Resistance Level N/A $30.94
Average True Range (ATR) 0.80 2.65
MACD 0.15 0.39
Stochastic Oscillator 88.94 56.38

Price Performance

Historical Comparison
ORN
STRO

About ORN Orion Group Holdings Inc.

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada, and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. The concrete segment generates maximum revenue and provides construction services for commercial, industrial, multi-family residential, and public projects, including the data center market.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: